Lymphangiogenesis is a feature of acute GVHD, and VEGFR-3 inhibition protects against experimental GVHD.
| Image |  |
|---|---|
| Description | scientific article published on 17 January 2017 |
| Author/s | |
| Publication date | January 17, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |